CN113316818A - 新生抗原的鉴定方法 - Google Patents
新生抗原的鉴定方法 Download PDFInfo
- Publication number
- CN113316818A CN113316818A CN202080008090.2A CN202080008090A CN113316818A CN 113316818 A CN113316818 A CN 113316818A CN 202080008090 A CN202080008090 A CN 202080008090A CN 113316818 A CN113316818 A CN 113316818A
- Authority
- CN
- China
- Prior art keywords
- tumor
- sequencing
- mutation
- gene
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (26)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910198582.1A CN111696628A (zh) | 2019-03-15 | 2019-03-15 | 新生抗原的鉴定方法 |
| CN2019101985821 | 2019-03-15 | ||
| PCT/CN2020/079131 WO2020187143A1 (zh) | 2019-03-15 | 2020-03-13 | 新生抗原的鉴定方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113316818A true CN113316818A (zh) | 2021-08-27 |
| CN113316818B CN113316818B (zh) | 2024-04-02 |
Family
ID=72475381
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910198582.1A Pending CN111696628A (zh) | 2019-03-15 | 2019-03-15 | 新生抗原的鉴定方法 |
| CN202080008090.2A Active CN113316818B (zh) | 2019-03-15 | 2020-03-13 | 新生抗原的鉴定方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910198582.1A Pending CN111696628A (zh) | 2019-03-15 | 2019-03-15 | 新生抗原的鉴定方法 |
Country Status (2)
| Country | Link |
|---|---|
| CN (2) | CN111696628A (zh) |
| WO (1) | WO2020187143A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115295084A (zh) * | 2022-08-05 | 2022-11-04 | 南开大学 | 一种肿瘤新抗原免疫组库数据可视化分析方法和系统 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118326008A (zh) * | 2024-04-18 | 2024-07-12 | 香港大学深圳医院 | 一种基于panel基因测序数据的肿瘤新抗原、筛选方法及应用 |
| CN118351934B (zh) * | 2024-04-26 | 2025-01-28 | 广州润生细胞医药科技有限责任公司 | 一种基于二代测序数据的肿瘤新抗原识别方法及系统 |
| CN119446264B (zh) * | 2025-01-09 | 2025-05-06 | 天津市肿瘤医院空港医院 | 一种恶性实体肿瘤的新抗原预测方法及系统 |
| CN120319309A (zh) * | 2025-03-28 | 2025-07-15 | 贵州生诺生物科技有限公司 | 一种抗原检测系统及其方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170016075A1 (en) * | 2015-07-14 | 2017-01-19 | Personal Genome Diagnostics, Inc. | Neoantigen analysis |
| WO2017024006A1 (en) * | 2015-08-03 | 2017-02-09 | The Johns Hopkins University | Personalized, allogeneic cell therapy of cancer |
| US20170199961A1 (en) * | 2015-12-16 | 2017-07-13 | Gritstone Oncology, Inc. | Neoantigen Identification, Manufacture, and Use |
| CN107636162A (zh) * | 2015-06-01 | 2018-01-26 | 加利福尼亚技术学院 | 用针对特定群体的抗原筛选t细胞的组合物和方法 |
| CN107704727A (zh) * | 2017-11-03 | 2018-02-16 | 杭州风起智能科技有限公司 | 基于肿瘤新抗原特征值的新抗原活性预测和排序方法 |
| CN108388773A (zh) * | 2018-02-01 | 2018-08-10 | 杭州纽安津生物科技有限公司 | 一种肿瘤新生抗原的鉴定方法 |
| CN108491689A (zh) * | 2018-02-01 | 2018-09-04 | 杭州纽安津生物科技有限公司 | 基于转录组的肿瘤新抗原鉴定方法 |
| WO2018183544A1 (en) * | 2017-03-31 | 2018-10-04 | Dana-Farber Cancer Institute, Inc. | Method for identification of retained intron tumor neoantigens from patient transcriptome |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108796055B (zh) * | 2018-06-12 | 2022-04-08 | 深圳裕策生物科技有限公司 | 基于二代测序的肿瘤新生抗原检测方法、装置和存储介质 |
| CN109021062B (zh) * | 2018-08-06 | 2021-08-20 | 倍而达药业(苏州)有限公司 | 一种肿瘤新抗原的筛选方法 |
-
2019
- 2019-03-15 CN CN201910198582.1A patent/CN111696628A/zh active Pending
-
2020
- 2020-03-13 CN CN202080008090.2A patent/CN113316818B/zh active Active
- 2020-03-13 WO PCT/CN2020/079131 patent/WO2020187143A1/zh not_active Ceased
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107636162A (zh) * | 2015-06-01 | 2018-01-26 | 加利福尼亚技术学院 | 用针对特定群体的抗原筛选t细胞的组合物和方法 |
| US20170016075A1 (en) * | 2015-07-14 | 2017-01-19 | Personal Genome Diagnostics, Inc. | Neoantigen analysis |
| WO2017024006A1 (en) * | 2015-08-03 | 2017-02-09 | The Johns Hopkins University | Personalized, allogeneic cell therapy of cancer |
| US20170199961A1 (en) * | 2015-12-16 | 2017-07-13 | Gritstone Oncology, Inc. | Neoantigen Identification, Manufacture, and Use |
| CN108601731A (zh) * | 2015-12-16 | 2018-09-28 | 磨石肿瘤生物技术公司 | 新抗原的鉴别、制造及使用 |
| WO2018183544A1 (en) * | 2017-03-31 | 2018-10-04 | Dana-Farber Cancer Institute, Inc. | Method for identification of retained intron tumor neoantigens from patient transcriptome |
| CN107704727A (zh) * | 2017-11-03 | 2018-02-16 | 杭州风起智能科技有限公司 | 基于肿瘤新抗原特征值的新抗原活性预测和排序方法 |
| CN108388773A (zh) * | 2018-02-01 | 2018-08-10 | 杭州纽安津生物科技有限公司 | 一种肿瘤新生抗原的鉴定方法 |
| CN108491689A (zh) * | 2018-02-01 | 2018-09-04 | 杭州纽安津生物科技有限公司 | 基于转录组的肿瘤新抗原鉴定方法 |
Non-Patent Citations (2)
| Title |
|---|
| JEANNE MENEZ-JAMET等: "Optimized tumor cryptic peptides: the basis for universal neoantigen- like tumor vaccines", ANNALS OF TRANSLATIONAL MEDICINE, vol. 14, no. 4, 22 April 2016 (2016-04-22), pages 1 - 11 * |
| 高志博等: "肿瘤精准免疫治疗与基因检测", 生物产业技术, vol. 02, 28 February 2017 (2017-02-28), pages 27 - 33 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115295084A (zh) * | 2022-08-05 | 2022-11-04 | 南开大学 | 一种肿瘤新抗原免疫组库数据可视化分析方法和系统 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113316818B (zh) | 2024-04-02 |
| WO2020187143A1 (zh) | 2020-09-24 |
| CN111696628A (zh) | 2020-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7530455B2 (ja) | 新生抗原の特定、製造、及び使用 | |
| CN113316818B (zh) | 新生抗原的鉴定方法 | |
| EP2872653B1 (en) | Personalized cancer vaccines and adoptive immune cell therapies | |
| JP2025175055A (ja) | 新生抗原のためのジャンクションエピトープ提示の低減 | |
| JP7034931B2 (ja) | ネオエピトープのウイルス送達のための改善された組成物および方法ならびにその使用 | |
| CN108601820A (zh) | 用于病毒癌症新表位的组合物和方法 | |
| CN110720127A (zh) | 新抗原的鉴别、制造及使用 | |
| US11485784B2 (en) | Ranking system for immunogenic cancer-specific epitopes | |
| JP2019513021A (ja) | ネオエピトープ提示のための配列の配置および配列 | |
| JP2019511907A (ja) | 癌免疫療法の治療標的としての患者特異的ネオエピトープのハイスループット同定 | |
| CN108700592A (zh) | 新表位的迭代发现及其适应性免疫疗法和方法 | |
| EP3362929B1 (en) | Viral neoepitopes and uses thereof | |
| TW202517684A (zh) | 選擇新抗原的方法、癌症疫苗組成物及其製備方法 | |
| CN112210596B (zh) | 基于基因融合事件的肿瘤新生抗原预测方法及其应用 | |
| EP4419716A1 (en) | Cancer neoantigens | |
| US20220296642A1 (en) | Methods of Making Therapeutic T Lymphocytes | |
| CN118561958B (zh) | 肺癌新抗原多肽及其应用 | |
| WO2025168848A1 (en) | Hla tumor antigen polypeptides with delivering aiding capping peptides and pharmaceutical composition comprising the same | |
| HK40013532A (zh) | 致免疫性的癌症特异抗原决定位的排名系统 | |
| HK1258093B (zh) | 病毒新表位及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20220816 Address after: Unit 202-1, No. 817, Lianting Road, Xiang'an District, Xiamen City, Fujian Province Applicant after: Trace Biomedical Technology (Xiamen) Co., Ltd. Address before: 14 / F, far east development building, 121 Des Voeux Road Central, Hong Kong, China Applicant before: Mark Zhun Biotechnology Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240926 Address after: G605, Student Science Building, Jiangwan Campus, Fudan University, No. 2005 Songhu Road, Yangpu District, Shanghai, 200433 Patentee after: Jiang Ning Country or region after: China Address before: Unit 202-1, No. 817 Lianting Road, Xiang'an District, Xiamen City, Fujian Province, 361100 Patentee before: Trace Biomedical Technology (Xiamen) Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |